Autonóm És alkalmazkodás figo iiic ovarian cancer Kellemetlenül kipiheni magát juh
Ovarian Cancer, the Revised FIGO Staging System, and the Role of Imaging
IJERPH | Free Full-Text | Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
Quality Indicators and Survival Outcome in Stage IIIB-IVB Epithelial Ovarian Cancer Treated at a Single Institution | In Vivo
World J Oncol
Primary Debulking Surgery for Stage III Epithelial Ovarian Cancer Has a Better Outcome Than Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery
Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival | Journal of Translational Medicine | Full Text
Ovarian Cancer (23.09.2011)
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials - du Bois - 2009 - Cancer - Wiley Online Library
Ovarian Cancer Overview: Molecular Biology and Its Potential Clinical Application | IntechOpen
PDF) Should we modify the current FIGO staging system for stage IIIC ovarian cancer? | Hee-Sug Ryu - Academia.edu
Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian cancer
Overall survival of patients with stage III ovarian cancer according to... | Download Scientific Diagram
Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study